NASDAQ: ENTO's Grid AI Strikes Texas Hyperscale Deal as its $50M Industrial Software Platform Enters the AI Race

Tip Ranks
2025.11.19 14:00
portai
I'm PortAI, I can summarize articles.

Entero Therapeutics' subsidiary, Grid AI, has signed a Letter of Intent with a stealth hyperscale AI developer in Texas. Grid AI's industrial software platform, with over $50 million invested, will provide energy orchestration for multi-campus AI facilities. This partnership is expected to generate significant revenue, with projections of $8 million in annual recurring revenue by 2027, scaling to over $50 million by 2029. Grid AI's platform is designed for mission-critical, industrial-grade performance, positioning it ahead of typical pre-revenue SaaS companies.